drugset / Trial / NCT00701207

Study of Nicotine Patches in Patients With Sarcoidosis

NCT00701207

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare peoples with disease (sarcoidosis) to those without disease. We want to see if people with sarcoidosis have a different immune response to those people without disease. The goal of this study is to see if the nicotine patch is an anti-inflammatory treatment for sarcoidosis.

Timeline

Start
2008-07
Primary completion
2010-12-31
Completion
2010-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 7 mg Other
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other

Indications